rosiglitazone has been researched along with Polycystic Ovarian Syndrome in 65 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 37 (56.92) | 29.6817 |
| 2010's | 21 (32.31) | 24.3611 |
| 2020's | 7 (10.77) | 2.80 |
| Authors | Studies |
|---|---|
| Abdalla, MA; Al-Rifai, RH; Atkin, SL; Deshmukh, H; Östlundh, L; Sahebkar, A; Sathyapalan, T; Shah, N | 2 |
| Chen, A; Jin, R; Lu, J; Ren, Y; Xuan, F; Ye, Y; Zhou, W | 2 |
| Bhat, D; Butt, TP; Choh, N; Ganie, MA; Gupta, N; Masoodi, SR; Nisar, S; Rashid, A; Sofi, NY; Sood, M; Wani, IA | 1 |
| Duan, C; Hu, Y; Huang, W; Li, Y; Tan, J; Wang, Q | 1 |
| Arya, S; Hansen, KR; Wild, RA | 1 |
| Ayala, A; Biller, BMK; Bonert, V; Broder, MS; Carmichael, JD; Cherepanov, D; Eagan, M; Geer, EB; Gordon, MB; Hannoush, Z; Katznelson, L; Lalazar, Y; Lee, J; Manuylova, E; Neary, MP; Pulaski-Liebert, KJ; Said, Q; Shafiq, I; Surampudi, V; Swerdloff, RS | 1 |
| Balen, AH; Morley, LC; Norman, RJ; Tang, T; Yasmin, E | 1 |
| Alexandraki, KI; Apostolopoulos, NV; Berry, R; Jude, EB; Mohiyiddeen, L; Watson, AJ | 1 |
| Chen, L; Hu, WH; Mao, S; Qiao, J; Tong, J; Zhao, CY | 1 |
| Abi Salloum, B; Beckett, E; Herkimer, C; Moeller, J; Padmanabhan, V; Sreedharan, R; Veiga-Lopez, A | 1 |
| Beckett, E; Cardoso, RC; Chazenbalk, G; Dumesic, D; Keller, E; Madrigal, V; Moeller, J; Padmanabhan, V; Pease, A; Veiga-Lopez, A | 1 |
| Chen, L; Hu, WH; Mao, S; Qiao, J; Zou, DY | 1 |
| Bucher, KG; Wiltz, SA | 1 |
| Burns, A; Cardoso, RC; Moeller, J; Padmanabhan, V; Skinner, DC | 1 |
| Janez, A; Jensterle, M; Keber, I; Kocjan, T; Pfeifer, M; Prezelj, J; Sebestjen, M | 1 |
| Aubuchon, M; Haddad, GF; Jodicke, C; Thomas, MA; Williams, DB | 1 |
| El-Kannishy, G; Shokeir, T | 1 |
| Mitkov, M; Pekhlivanov, B | 1 |
| Baruah, J; Kachava, G; Karmakar, D; Kumar, S; Roy, KK; Sharma, A; Sharma, JB | 1 |
| Lee, JS; Padmanabhan, V; Veiga-Lopez, A | 1 |
| Li, XJ; Liu, CQ; Wang, LY; Yan, B; Yang, SY; Yu, YX; Zhang, HJ; Zhang, SH; Zhang, W | 1 |
| Arslanian, S; Lee, S; Sutton-Tyrrell, K; Tfayli, H; Ulnach, JW | 1 |
| Dong, JJ; Liao, L; Tian, YJ; Xin, Y; Xing, HY; Zhao, JJ | 1 |
| Balakhonova, TV; Blinova, IV; Chernukha, GE; Karpov, IuA | 1 |
| Hu, W; Qiao, J | 1 |
| Chan, JC; Chan, MH; Cheung, LP; Chow, FC; Haines, CJ; Lam, CW; Lam, PM; Ma, RC; Tam, WH; Tong, PC; Tsui, MH | 1 |
| Mohsen, IA | 1 |
| Chen, J; Cui, R; Guo, L; Huang, MQ; Li, HM; Miao, ZL; Qin, WB; Wang, YX; Wang, ZN; Wei, XC; Yang, N | 1 |
| Baracat, EC; Batista, JG; Maganhin, CC; Simões, RS; Soares, JM; Tomaz, G | 1 |
| Du, Q; Fan, B; Wang, YJ; Wu, B; Yang, S; Zhao, YY | 1 |
| Li, M; Lin, Y; Ma, Y; Zheng, Z | 1 |
| Shaarawy, M; Shobokshi, A | 1 |
| Bryer-Ash, M; Ghazeeri, G; Haas, D; Ke, RW; Kutteh, WH | 1 |
| Plosker, SM | 1 |
| Flight, IH; Lord, JM; Norman, RJ | 1 |
| Belli, SH; Graffigna, MN; Levalle, OA; Oneto, A; Otero, P; Schurman, L | 1 |
| Gao, HY; Jia, P; Zhang, CL; Zhao, ZG | 1 |
| Baillargeon, JP; Iuorno, MJ; Jakubowicz, DJ; Jakubowicz, S; Nestler, JE | 1 |
| Nagamani, M; Sepilian, V | 1 |
| Aslan, E; Bagis, T; Erkanli, S; Haydardedeoglu, B; Kilicdag, EB; Tarim, E; Zeyneloglu, HB | 1 |
| Liu, Y; Lv, L | 1 |
| Cantürk, Z; Cetinarslan, B; Komsuoglu, B; Sahin, T; Tarkun, I; Türemen, E | 1 |
| Bayraktar, F; Dereli, D; Dereli, T; Ozgen, AG; Yilmaz, C | 1 |
| Arslan, M; Ayvaz, G; Bukan, N; Cakir, N; Karakoç, A; Törüner, F; Yilmaz, M | 1 |
| Bell, DS; Vaughan, TB | 1 |
| Abbasi, F; Basina, M; Cataldo, NA; Fechner, PY; Giudice, LC; McLaughlin, TL; Reaven, GM | 1 |
| Déchêne, F; Dodin, S; Forest, JC; Lemay, A; Turcot, L | 1 |
| Arslan, M; Ayvaz, G; Cakir, N; Karakoç, A; Tiras, B; Törüner, FB; Yilmaz, M | 1 |
| Mitkov, M; Pehlivanov, B; Terzieva, D | 1 |
| Arslan, M; Ayvaz, G; Bingöl, B; Biri, A; Cakir, N; Karakoç, A; Tiras, B; Törüner, F; Yilmaz, M | 1 |
| Morin-Papunen, LC; Rautio, K; Ruokonen, A; Tapanainen, JS | 2 |
| Ardawi, MS; Rouzi, AA | 1 |
| Chan, LY; Chow, KM; Fung, TM; Lau, TK | 1 |
| Elhadd, TA; Fiad, T; Meer, L | 1 |
| Kesäniemi, YA; Kunnari, A; Majuri, A; Morin-Papunen, L; Rautio, K; Ruokonen, A; Santaniemi, M; Tapanainen, JS; Ukkola, O; Vartiainen, J | 1 |
| Demers, LM; Dodson, WC; Gnatuk, CL; Kunselman, AR; Legro, RS; Williams, NI; Zaino, RJ | 1 |
| Atanasova, I; Genchev, G; Kamenov, Z; Khristov, V; Kolarov, G; Milcheva, B; Orbetsova, M; Shigarminova, R; Zakharieva, S | 1 |
| Bohdanowicz-Pawlak, A; Jakubowska, J; Milewicz, A | 1 |
| Atkin, SL; Cho, LW | 1 |
| Glueck, C; Goldenberg, N | 1 |
| Janez, A; Jensterle, M; Marc, J; Mlinar, B; Pfeifer, M; Prezelj, J | 1 |
| Abbasi, F; Cataldo, NA; Lamendola, C; McLaughlin, TL; Reaven, GM | 1 |
9 review(s) available for rosiglitazone and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Impact of pharmacological interventions on anthropometric indices in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials.
Topics: Acarbose; Body Weight; Female; Humans; Hypoglycemic Agents; Metformin; Orlistat; Pioglitazone; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Rosiglitazone | 2022 |
Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
Topics: Androgens; Dexamethasone; Female; Flutamide; Humans; Hyperandrogenism; Metformin; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Rosiglitazone; Testosterone | 2023 |
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Topics: Abortion, Spontaneous; Anovulation; Clomiphene; Female; Humans; Hypoglycemic Agents; Infertility, Female; Inositol; Insulin Resistance; Live Birth; Metformin; Ovulation Induction; Pioglitazone; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones | 2017 |
Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis.
Topics: Dehydroepiandrosterone Sulfate; Diarrhea; Female; Humans; Hypoglycemic Agents; Metformin; Nausea; Pioglitazone; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Rosiglitazone; Testosterone; Thiazolidinediones; Time Factors; Treatment Outcome; Triglycerides | 2011 |
Effects of thiazolidinediones on polycystic ovary syndrome: a meta-analysis of randomized placebo-controlled trials.
Topics: Androgens; Blood Glucose; Body Weight; Female; Humans; Insulin; Insulin Resistance; Pioglitazone; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones | 2012 |
Polycystic ovary syndrome and insulin resistance.
Topics: Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Polycystic Ovary Syndrome; Prevalence; Risk Factors; Rosiglitazone; Thiazoles; Thiazolidinediones; United States; Women's Health | 2003 |
Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
Topics: Anovulation; Chromans; Female; Humans; Hypoglycemic Agents; Inositol; Metformin; Ovulation Induction; Pioglitazone; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone | 2003 |
Cardiovascular risk in women with polycystic ovary syndrome.
Topics: Atherosclerosis; Biomarkers; Body Weight; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Exercise; Female; Humans; Hypoglycemic Agents; Metformin; Pioglitazone; Polycystic Ovary Syndrome; Risk Factors; Risk Reduction Behavior; Rosiglitazone; Thiazolidinediones; Vasodilator Agents; Weight Loss | 2007 |
Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation.
Topics: Adult; Clomiphene; Diabetes, Gestational; Drug Therapy, Combination; Female; Fertility Agents, Female; Humans; Hypoglycemic Agents; Infant, Newborn; Lactation; Metformin; Ovulation Induction; Pioglitazone; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones | 2008 |
31 trial(s) available for rosiglitazone and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Coadministration of metformin or spironolactone enhances efficacy of rosiglitazone in management of PCOS.
Topics: Adolescent; Adult; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hyperandrogenism; India; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Rosiglitazone; Spironolactone; Treatment Outcome; Young Adult | 2020 |
Comparing the individual effects of metformin and rosiglitazone and their combination in obese women with polycystic ovary syndrome: a randomized controlled trial.
Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Rosiglitazone; Treatment Outcome; Waist Circumference; Young Adult | 2020 |
Effects of low-dose metformin and rosiglitazone on biochemical, clinical, metabolic and biophysical outcomes in polycystic ovary syndrome.
Topics: Adult; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Hypoglycemic Agents; Metformin; Ovary; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Ultrasonography | 2013 |
Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome.
Topics: Androgens; Brachial Artery; C-Reactive Protein; Cardiovascular Diseases; Endothelium, Vascular; Female; Homeostasis; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Menstrual Cycle; Metformin; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones; Vasodilation | 2008 |
A prospective randomized trial comparing the clinical and endocrinological outcome with rosiglitazone versus laparoscopic ovarian drilling in patients with polycystic ovarian disease resistant to ovulation induction with clomiphene citrate.
Topics: Adult; Clomiphene; Drug Resistance; Female; Fertility Agents, Female; Humans; Hypoglycemic Agents; Laparoscopy; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Prospective Studies; Rosiglitazone; Thiazolidinediones; Young Adult | 2010 |
Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.
Topics: Adolescent; Adrenocorticotropic Hormone; Androstenes; Body Composition; Cardiovascular Diseases; Double-Blind Method; Ethinyl Estradiol; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hemodynamics; Hormones; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Overweight; Polycystic Ovary Syndrome; Risk Factors; Rosiglitazone; Stimulation, Chemical; Thiazolidinediones | 2011 |
Metformin versus metformin plus rosiglitazone in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Luteinizing Hormone; Metformin; Polycystic Ovary Syndrome; Rosiglitazone; Testosterone; Thiazolidinediones; Triglycerides; Young Adult | 2011 |
The reproductive and metabolic effect of rosiglitazone on Chinese women with polycystic ovarian syndrome--a double-blind randomized placebo-controlled study.
Topics: Adult; Amenorrhea; Asian People; Chi-Square Distribution; Double-Blind Method; Female; Hong Kong; Humans; Hyperandrogenism; Hypoglycemic Agents; Menstrual Cycle; Placebo Effect; Polycystic Ovary Syndrome; Rosiglitazone; Testosterone; Thiazolidinediones; Time Factors; Treatment Outcome; Young Adult | 2011 |
A randomized controlled trial of the effect of rosiglitazone and clomiphene citrate versus clomiphene citrate alone in overweight/obese women with polycystic ovary syndrome.
Topics: Adult; Blood Glucose; Clomiphene; Drug Therapy, Combination; Female; Fertility Agents, Female; Humans; Hypoglycemic Agents; Infertility, Female; Insulin; Insulin Resistance; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Young Adult | 2012 |
Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study.
Topics: Adult; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Pilot Projects; Polycystic Ovary Syndrome; Rosiglitazone; Statistics, Nonparametric; Thiazolidinediones | 2012 |
[Effect of rosiglitazone on insulin resistance and hyperandrogenism in polycystic ovary syndrome].
Topics: Administration, Oral; Adult; Androstenedione; Blood Glucose; Body Weight; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin; Insulin Resistance; Leptin; Lipids; Luteinizing Hormone; Menstruation; Neuropeptide Y; Ovulation; Polycystic Ovary Syndrome; Rosiglitazone; Testosterone; Thiazoles; Thiazolidinediones; Treatment Outcome | 2002 |
Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy.
Topics: Adult; Area Under Curve; Clomiphene; Drug Therapy, Combination; Estrogen Antagonists; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Luteinizing Hormone; Menstruation; Polycystic Ovary Syndrome; Rosiglitazone; Thiazoles; Thiazolidinediones | 2003 |
Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Blood Glucose; Clomiphene; Deamino Arginine Vasopressin; Dehydroepiandrosterone Sulfate; Double-Blind Method; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Ovulation Induction; Placebos; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Rosiglitazone; Sex Hormone-Binding Globulin; Testosterone; Thiazoles; Thiazolidinediones | 2003 |
Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Body Mass Index; Female; Glucose Tolerance Test; Growth Substances; Humans; Hypoglycemic Agents; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Luteinizing Hormone; Menstruation; Polycystic Ovary Syndrome; Pregnancy; Prospective Studies; Reproduction; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2004 |
[Effect of rosiglitazone on ovulation induction in women with polycystic ovary syndrome].
Topics: Adult; Female; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Ovulation Induction; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2004 |
Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.
Topics: Adolescent; Adult; Blood Glucose; Dehydroepiandrosterone Sulfate; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Ovulation; Polycystic Ovary Syndrome; Rosiglitazone; Sex Hormone-Binding Globulin; Testosterone; Thiazolidinediones; Venezuela | 2004 |
Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
Topics: Adult; Anovulation; Blood Glucose; Body Weight; Female; Folic Acid; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Luteinizing Hormone; Metformin; Polycystic Ovary Syndrome; Rosiglitazone; Testosterone; Thiazolidinediones; Vitamin B 12 | 2005 |
Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in non-obese young women with polycystic ovary syndrome.
Topics: Adult; Biomarkers; Body Weight; C-Reactive Protein; Endothelium, Vascular; Female; Hormones; Humans; Hypoglycemic Agents; Insulin Resistance; Muscle, Smooth, Vascular; Obesity; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones; Vasculitis | 2005 |
Endocrine and metabolic effects of rosiglitazone in non-obese women with polycystic ovary disease.
Topics: Adult; Androstenedione; Blood Glucose; Body Mass Index; Dose-Response Relationship, Drug; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Glycated Hemoglobin; Hirsutism; Humans; Hypoglycemic Agents; Insulin; Luteinizing Hormone; Ovulation; Polycystic Ovary Syndrome; Rosiglitazone; Testosterone; Thiazolidinediones | 2005 |
The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
Topics: Adult; Androgens; Antioxidants; Blood Glucose; Body Mass Index; Body Weight; Female; Homeostasis; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Malondialdehyde; Metformin; Models, Statistical; Oxidative Stress; Polycystic Ovary Syndrome; Risk Factors; Rosiglitazone; Smoking; Thiazolidinediones; Time Factors | 2005 |
Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome.
Topics: Blood Glucose; Female; Hemorrhage; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Luteinizing Hormone; Menstruation; Ovary; Ovulation; Polycystic Ovary Syndrome; Rosiglitazone; Sex Hormone-Binding Globulin; Testosterone; Thiazolidinediones; Vagina | 2006 |
Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance.
Topics: Adolescent; Adult; Androgens; Blood Glucose; Cholesterol, HDL; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Insulin; Insulin Resistance; Middle Aged; Obesity; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones | 2006 |
The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.
Topics: Adult; Androstenedione; Female; Glucose Tolerance Test; Hirsutism; Humans; Hypoglycemic Agents; Insulin; Menstrual Cycle; Metformin; Polycystic Ovary Syndrome; Rosiglitazone; Testosterone; Thiazolidinediones; Treatment Outcome | 2005 |
Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.
Topics: Adult; Body Mass Index; Dehydroepiandrosterone Sulfate; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipid Metabolism; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Rosiglitazone; Sex Hormone-Binding Globulin; Testosterone; Thiazolidinediones; Waist-Hip Ratio | 2006 |
Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Area Under Curve; Dehydroepiandrosterone; Double-Blind Method; Female; Glucose Tolerance Test; Humans; Overweight; Placebos; Polycystic Ovary Syndrome; Rosiglitazone; Sex Hormone-Binding Globulin; Thiazolidinediones | 2006 |
A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome.
Topics: Adult; Clomiphene; Drug Resistance; Drug Therapy, Combination; Female; Fertility Agents, Female; Hormones; Humans; Metformin; Ovarian Follicle; Ovulation; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Ultrasonography | 2006 |
Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study.
Topics: Adolescent; Adult; Female; Humans; Hypoglycemic Agents; Inflammation; Liver Diseases; Obesity; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2007 |
Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study.
Topics: Adiponectin; Adult; Female; Ghrelin; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Peptide Hormones; Placebos; Polycystic Ovary Syndrome; Resistin; Rosiglitazone; Thiazolidinediones | 2007 |
The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome.
Topics: Adult; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endometrium; Female; Follow-Up Studies; Humans; Immunohistochemistry; Linear Models; Metformin; Ovary; Polycystic Ovary Syndrome; Probability; Prospective Studies; Rosiglitazone; Single-Blind Method; Thiazolidinediones; Treatment Outcome | 2007 |
[The effect of rosiglitazone on plasma adiponectin and resistin levels in obese PCO woman--preliminary report].
Topics: Adiponectin; Adolescent; Adult; Body Mass Index; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Middle Aged; Obesity; Polycystic Ovary Syndrome; Resistin; Rosiglitazone; Thiazolidinediones; Triglycerides | 2007 |
Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Analysis of Variance; Androgens; Female; Gene Expression; Glucose Transporter Type 4; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Time Factors | 2008 |
25 other study(ies) available for rosiglitazone and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
The effect of sitagliptin combined with rosiglitazone on autophagy and inflammation in polycystic ovary syndrome by regulating PI3K/AKT/mTOR and TLR4/NF-κB pathway.
Topics: Animals; Autophagy; Blood Glucose; Body Weight; Female; Gonadal Steroid Hormones; Inflammation; Insulins; Interleukin-18; Interleukin-6; NF-kappa B; Phosphatidylinositol 3-Kinases; Polycystic Ovary Syndrome; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger; Rosiglitazone; Toll-Like Receptor 4; TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha | 2023 |
The ameliorating effects of Guizhi Fuling Wan combined with rosiglitazone in a rat ovarian model of polycystic ovary syndrome by the PI3K/AKT/NF-κB and Nrf2/HO-1 pathways.
Topics: Animals; Dehydroepiandrosterone; Female; Humans; NF-E2-Related Factor 2; NF-kappa B; Phosphatidylinositol 3-Kinases; Polycystic Ovary Syndrome; Proto-Oncogene Proteins c-akt; Rats; Rosiglitazone | 2023 |
Metformin, rosiglitazone, or both for obese women with polycystic ovary syndrome?
Topics: Female; Humans; Hypoglycemic Agents; Metformin; Obesity; Polycystic Ovary Syndrome; Rosiglitazone | 2020 |
BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY.
Topics: 14-alpha Demethylase Inhibitors; ACTH-Secreting Pituitary Adenoma; Adenoma; Adolescent; Adrenalectomy; Adult; Aged; Antineoplastic Agents; Cabergoline; Comorbidity; Enzyme Inhibitors; Ergolines; Female; Follow-Up Studies; Hirsutism; Hormone Antagonists; Hormones; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Ketoconazole; Male; Metyrapone; Middle Aged; Mifepristone; Muscle Weakness; Muscular Atrophy; Neurosurgical Procedures; Obesity, Abdominal; Pituitary ACTH Hypersecretion; Pituitary Irradiation; Polycystic Ovary Syndrome; Retrospective Studies; Rosiglitazone; Somatostatin; Striae Distensae; Thiazolidinediones; Treatment Outcome; Tumor Burden; Young Adult | 2017 |
[Expression of PPARγ mRNA in granulosa cells and its correlation with clinical characteristics of polycystic ovary syndrome].
Topics: Adult; Female; Granulosa Cells; Humans; Insulin; Polycystic Ovary Syndrome; PPAR gamma; RNA, Messenger; Rosiglitazone; Testosterone; Thiazolidinediones | 2013 |
Developmental Programming: Prenatal and Postnatal Androgen Antagonist and Insulin Sensitizer Interventions Prevent Advancement of Puberty and Improve LH Surge Dynamics in Prenatal Testosterone-Treated Sheep.
Topics: Androgen Antagonists; Androgens; Animals; Estrous Cycle; Female; Fetal Development; Flutamide; Hypoglycemic Agents; Luteinizing Hormone; Metformin; Polycystic Ovary Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Rosiglitazone; Sexual Maturation; Sheep; Sheep, Domestic; Testosterone; Thiazolidinediones | 2015 |
Developmental Programming: Impact of Gestational Steroid and Metabolic Milieus on Adiposity and Insulin Sensitivity in Prenatal Testosterone-Treated Female Sheep.
Topics: Adiposity; Animals; Disease Models, Animal; Embryonic Development; Female; Flutamide; Insulin Resistance; Obesity; Polycystic Ovary Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Rosiglitazone; Sheep; Testosterone; Thiazolidinediones | 2016 |
[Expression and regulation of CD36 mRNA in granulosa cells and its relation with clinical characteristics of polycystic ovary syndrome].
Topics: CD36 Antigens; Female; Granulosa Cells; Humans; Insulin; Polycystic Ovary Syndrome; PPAR gamma; Real-Time Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Testosterone; Thiazolidinediones | 2016 |
Alternatives to Metformin for Patients with PCOS.
Topics: Evidence-Based Medicine; Family Practice; Female; Humans; Metformin; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones; United States | 2016 |
Developmental Programming: Insulin Sensitizer Prevents the GnRH-Stimulated LH Hypersecretion in a Sheep Model of PCOS.
Topics: Androgen Antagonists; Androgens; Animals; Disease Models, Animal; Estrogen Receptor alpha; Female; Flutamide; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Luteinizing Hormone, beta Subunit; Pituitary Gland; Polycystic Ovary Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Receptor, Insulin; Receptors, Androgen; Rosiglitazone; Sheep; Testosterone; Thiazolidinediones | 2016 |
Case series of rosiglitazone used during the first trimester of pregnancy.
Topics: Adult; Anovulation; Female; Humans; Hypoglycemic Agents; Infant, Newborn; Ovulation; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Rosiglitazone; Thiazolidinediones | 2008 |
Rosiglitazone as treatment for clomiphene citrate-resistant polycystic ovary syndrome: factors associated with clinical response.
Topics: Adult; Anovulation; Body Mass Index; Clomiphene; Drug Resistance; Egypt; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Hypoglycemic Agents; Infertility, Female; Luteinizing Hormone; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Regression Analysis; Retrospective Studies; Risk Factors; Rosiglitazone; Selective Estrogen Receptor Modulators; Testosterone; Thiazolidinediones; Ultrasonography; Young Adult | 2008 |
[Use of rosiglitazone in women with polycystic ovarian syndrome].
Topics: Adolescent; Adult; Body Mass Index; Drug Administration Schedule; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Polycystic Ovary Syndrome; Prospective Studies; Rosiglitazone; Thiazolidinediones | 2005 |
Developmental programming: insulin sensitizer treatment improves reproductive function in prenatal testosterone-treated female sheep.
Topics: Animals; Drug Evaluation, Preclinical; Estrous Cycle; Female; Fetal Development; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Polycystic Ovary Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Reproduction; Rosiglitazone; Sheep; Testosterone; Thiazolidinediones | 2010 |
[Drug correction of hormonal disturbances and risk factors of cardiovascular complications in women of reproductive age with polycystic ovary syndrome].
Topics: Biomarkers; Cardiovascular Diseases; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Incidence; Luteinizing Hormone; Polycystic Ovary Syndrome; PPAR gamma; Radioimmunoassay; Reproduction; Risk Factors; Rosiglitazone; Russia; Testosterone; Thiazolidinediones; Treatment Outcome; Young Adult | 2010 |
Expression and regulation of adipocyte fatty acid binding protein in granulosa cells and its relation with clinical characteristics of polycystic ovary syndrome.
Topics: Adult; Body Mass Index; C-Reactive Protein; Cells, Cultured; Fatty Acid-Binding Proteins; Female; Gene Expression Regulation; Granulosa Cells; Humans; Hypercholesterolemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Obesity; Polycystic Ovary Syndrome; PPAR gamma; RNA, Messenger; Rosiglitazone; Severity of Illness Index; Testosterone; Thiazolidinediones; Up-Regulation | 2011 |
The intervention effect of Rosiglitozone in ovarian fibrosis of PCOS rats.
Topics: Animals; Connective Tissue Growth Factor; Female; Fibrosis; Hypoglycemic Agents; Ovary; Polycystic Ovary Syndrome; Random Allocation; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta | 2012 |
Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance.
Topics: Androgens; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Luteinizing Hormone; Obesity; Ovary; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones | 2005 |
Effect of rosiglitazone on endocrine, metabolism and ovulatory performance in patients with polycystic ovary syndrome and insulin resistance.
Topics: Adult; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hypoglycemic Agents; Insulin Resistance; Luteinizing Hormone; Ovulation Induction; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones | 2004 |
Stockpiling of ovarian follicles and the response to rosiglitazone.
Topics: Female; Humans; Hypoglycemic Agents; Infant, Newborn; Metformin; Middle Aged; Ovarian Follicle; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Rosiglitazone; Thiazolidinediones | 2005 |
The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.
Topics: Adult; Androgens; Blood Glucose; Body Mass Index; Fasting; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Hirsutism; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Luteinizing Hormone; Menstrual Cycle; Menstruation; Metformin; Obesity; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones; Thinness | 2005 |
Re: Effects of rosiglitazone on hormonal profile and ovulatory function in Chinese women with polycystic ovary syndrome.
Topics: Adult; China; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Luteinizing Hormone; Menstrual Cycle; Ovulation; Polycystic Ovary Syndrome; Progesterone; Prospective Studies; Rosiglitazone; Severity of Illness Index; Thiazolidinediones; Treatment Outcome | 2006 |
Ovarian stockpiling in polycystic ovary syndrome, infertility, and the combined use of rosiglitazone and metformin.
Topics: Adult; Diabetes Mellitus, Type 2; Female; Humans; Infertility, Female; Metformin; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Rosiglitazone; Thiazolidinediones | 2006 |
[Effect of 6-month treatment with oral antiandrogen alone and in combination with insulin sensitizers on body composition, hormonal and metabolic parameters in women with polycystic ovary syndrome (PCOS) in order to determine therapeutic strategy].
Topics: Androgen Antagonists; Blood Glucose; Body Composition; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin; Lipids; Metformin; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones; Time Factors; Treatment Outcome | 2006 |
Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone.
Topics: Adult; Female; Humans; Hypoglycemic Agents; Insulin; Ovulation; Polycystic Ovary Syndrome; Pregnancy; Rosiglitazone; Thiazoles; Thiazolidinediones | 2001 |